As online idn play technology continues to evolve, many players are drawn to platforms that emphasize accessibility and performance. A reliable situs idn poker generally offers intuitive navigation, secure account protection, and a wide selection of card games. These features help users focus on strategy and entertainment while enjoying a consistent gaming experience across different devices.

Many gaming enthusiasts search for a trusted link idn slot that offers stable connectivity and uninterrupted access to their favorite games. Fast-loading pages, responsive servers, and user-friendly features contribute significantly to player satisfaction. By prioritizing performance and accessibility, the link slot qris creates a comfortable environment where users can focus on enjoying entertainment without unnecessary technical obstacles or delays.

Access to reliable data macau lottery updates allows users to make informed observations based on verified information. The platform emphasizes clarity, speed, and transparency, ensuring that every published result is easy to review. For many visitors, comprehensive result macau resources serve as an essential reference point when exploring historical records and recent draw activity.

S 30 in Congressional Session 110

Official Summary

 

Bill Number : S 30
 

Title : A bill to intensify research to derive human pluripotent stem cell lines.
 

SUMMARY AS OF:
4/11/2007--Passed Senate without amendment.    (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act -

(Sec. 3)

Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefits; (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and (4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells. Sets forth reporting requirements. Authorizes appropriations.

(Sec. 4)

Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.

Votes

Title : A bill to intensify research to derive human pluripotent stem cell lines.
Votes in the US Senate
Roll Number Vote Date Question Description Vote Result
128 2007-04-11 On Passage of the Bill S. 30; HOPE Act P
Votes in the US House
This Bill was not Voted in the US House

Sponsors

 
Congressional Sponsors of S 30
 
Bill Number : S 30
Title : A bill to intensify research to derive human pluripotent stem cell lines.
Sponsor: Sen Coleman, Norm [MN] (introduced 3/29/2007)      
ALPHABETICAL [followed by Cosponsors withdrawn]:     (Sort: by date)

Sen Burr, Richard [NC] - 4/10/2007

Sen Chambliss, Saxby [GA] - 4/10/2007

Sen Coburn, Tom [OK] - 4/10/2007

Sen Cornyn, John [TX] - 4/10/2007

Sen Isakson, Johnny [GA] - 3/29/2007

Sen McConnell, Mitch [KY] - 4/10/2007

Other Info

Bill Number : S 30
Title : A bill to intensify research to derive human pluripotent stem cell lines.
 
MAJOR ACTIONS:
 
3/29/2007 Introduced in Senate
 
4/11/2007 Passed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128.
 
4/16/2007 Referred to House committee: Referred to the House Committee on Energy and Commerce.
 
ALL ACTIONS:
 
3/29/2007:Introduced in the Senate and read twice and ordered held at desk.
 
4/10/2007:Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)
 
4/11/2007:Considered by Senate. (consideration: CR S4319-4371, S4386-4391)
 
4/11/2007:Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128. (text as passed Senate: CR S4390-4391)
 
4/12/2007:Message on Senate action sent to the House.
 
4/16/2007 2:05pm:Received in the House.
 
4/16/2007:Referred to the House Committee on Energy and Commerce.